Cargando…
Randomised clinical trial comparing melatonin 3 mg, amitriptyline 25 mg and placebo for migraine prevention
INTRODUCTION: Melatonin has been studied in headache disorders. Amitriptyline is efficacious for migraine prevention, but its unfavourable side effect profile limits its use. METHODS: A randomised, double-blind, placebo-controlled study was carried out. Men and women, aged 18–65 years, with migraine...
Autores principales: | Gonçalves, Andre Leite, Martini Ferreira, Adriana, Ribeiro, Reinaldo Teixeira, Zukerman, Eliova, Cipolla-Neto, José, Peres, Mario Fernando Prieto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036209/ https://www.ncbi.nlm.nih.gov/pubmed/27165014 http://dx.doi.org/10.1136/jnnp-2016-313458 |
Ejemplares similares
-
Treatment satisfaction and efficacy of the rapid release formulation of sumatriptan 100 mg tablets utilising an early intervention paradigm in patients previously unsatisfied with sumatriptan
por: Newman, L C, et al.
Publicado: (2008) -
Migraine and risk of stroke
por: Øie, Lise R, et al.
Publicado: (2020) -
Diagnostic and therapeutic aspects of hemiplegic migraine
por: Di Stefano, Vincenzo, et al.
Publicado: (2020) -
Headache-related health resource utilisation in chronic and episodic migraine across six countries
por: Sanderson, Joanna C, et al.
Publicado: (2013) -
Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials
por: Reuter, Uwe, et al.
Publicado: (2019)